EX-16.1 2 f8k102218ex16-1_aytubio.htm LETTER FROM EKS&H LLLP DATED OCTOBER 22, 2018 TO THE SEC REGARDING STATEMENTS INCLUDED IN THIS FORM 8-K

Exhibit 16.1

October 22, 2018

Securities and Exchange Commission

Washington, D.C. 20549

Commissioners:

We have read Aytu BioScience, Inc.’s statements included under Item 4.01 of its Form 8-K filed on October 22, 2018 and we agree with such statements concerning our firm.

EKS&H LLLP